BM8 Intrinsic Valuation and Fundamental Analysis - Biomarin Pharmaceutical Inc

B	Biomarin Pharmaceutical Inc XMUN:BM8	US
A	Altria Group Inc XMUN:PHM7	US

Intrinsic Value

The intrinsic value for Biomarin Pharmaceutical Inc (BM8) under the Base Case is 53 EUR. Compared with the current market price of 57.21 EUR, the stock appears Overvalued by 7% .

Intrinsic value calculated using DCF

€53

Other reference points

Multiples estimate

€76.21

Wall St target

€79.55

Do our valuations actually work? See backtest results .

BM8 Intrinsic Value

Overvaluation 7%

Intrinsic Value

Price €57.21

Track Buy Zone

20% below Intrinsic Value €42.4

Get notified when the price drops into your buy zone

Current Price €57.21

Intrinsic Value €53

Margin of Safety 20% €42.4

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.

Explain Valuation